Zhejiang Ausun Pharmaceutical Co Ltd Market Cap ($871.14 Million)
Market Cap & Net Worth: Zhejiang Ausun Pharmaceutical Co Ltd (603229)
Zhejiang Ausun Pharmaceutical Co Ltd market cap. Zhejiang Ausun Pharmaceutical Co Ltd (SHG:603229) has a market capitalization of $871.14 Million (CN¥5.95 Billion) as of November 9, 2026. Listed on the SHG stock exchange, this China-based company holds position #9187 globally and #2244 in its home market, demonstrating a -0.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Ausun Pharmaceutical Co Ltd's stock price CN¥7.17 by its total outstanding shares 830297145 (830.30 Million). Also see Zhejiang Ausun Pharmaceutical Co Ltd (603229) cash conversion ratio for how efficiently the company converts equity into cash flow.
Zhejiang Ausun Pharmaceutical Co Ltd Market Cap History (2017–2026)
Zhejiang Ausun Pharmaceutical Co Ltd market cap history from 2017 to 2026. Data shows growth from $613.22 Million to $871.14 Million (8.37% CAGR). Check 603229 stock price and chart for real-time trading data and today's change.
Zhejiang Ausun Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Ausun Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 603229 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.52x
Zhejiang Ausun Pharmaceutical Co Ltd's market cap is 1.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
9.23x
Zhejiang Ausun Pharmaceutical Co Ltd's market cap is 9.23 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $613.22 Million | $240.19 Million | $53.01 Million | 2.55x | 11.57x |
| 2018 | $414.58 Million | $243.89 Million | $43.86 Million | 1.70x | 9.45x |
| 2019 | $737.40 Million | $307.91 Million | $56.39 Million | 2.39x | 13.08x |
| 2020 | $1.87 Billion | $409.25 Million | $86.84 Million | 4.57x | 21.54x |
| 2021 | $2.24 Billion | $569.70 Million | $145.93 Million | 3.92x | 15.32x |
| 2022 | $2.05 Billion | $764.55 Million | $235.38 Million | 2.68x | 8.71x |
| 2023 | $1.60 Billion | $816.77 Million | $253.90 Million | 1.97x | 6.32x |
| 2024 | $1.21 Billion | $795.29 Million | $206.79 Million | 1.53x | 5.87x |
| 2025 | $1.21 Billion | $792.76 Million | $130.57 Million | 1.52x | 9.23x |
Competitor Companies of 603229 by Market Capitalization
Companies near Zhejiang Ausun Pharmaceutical Co Ltd in the global market cap rankings as of November 9, 2026. Also see balance sheet size of Zhejiang Ausun Pharmaceutical Co Ltd for a full breakdown of the balance sheet.
Key companies related to Zhejiang Ausun Pharmaceutical Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Zhejiang Ausun Pharmaceutical Co Ltd (2017–2026)
Market capitalization of Zhejiang Ausun Pharmaceutical Co Ltd from 2017 to today. Between 2017 and today, Zhejiang Ausun Pharmaceutical Co Ltd's market cap moved from $613.22 Million to $ 871.14 Million, with a yearly change of 8.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥871.14 Million | -27.72% |
| 2025 | CN¥1.21 Billion | -0.70% |
| 2024 | CN¥1.21 Billion | -24.38% |
| 2023 | CN¥1.60 Billion | -21.72% |
| 2022 | CN¥2.05 Billion | -8.28% |
| 2021 | CN¥2.24 Billion | +19.53% |
| 2020 | CN¥1.87 Billion | +153.60% |
| 2019 | CN¥737.40 Million | +77.87% |
| 2018 | CN¥414.58 Million | -32.39% |
| 2017 | CN¥613.22 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 9th, 2026 the market cap of Zhejiang Ausun Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $871.14 Million USD |
| MoneyControl | $871.14 Million USD |
| MarketWatch | $871.14 Million USD |
| marketcap.company | $871.14 Million USD |
| Reuters | $871.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Ausun Pharmaceutical Co Ltd
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, … Read more